These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 26621208)

  • 1. Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy.
    Abdi H; Pourmalek F; Gleave ME; So AI; Black PC
    World J Urol; 2016 Jan; 34(1):41-8. PubMed ID: 26621208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer.
    Larcher A; Sun M; Schiffmann J; Tian Z; Shariat SF; McCormack M; Saad F; Fossati N; Abdollah F; Briganti A; Buffi N; Graefen M; Guazzoni G; Montorsi F; Karakiewicz PI
    Eur J Surg Oncol; 2015 Mar; 41(3):353-60. PubMed ID: 25477269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended vs non-extended pelvic lymph node dissection and their influence on recurrence-free survival in patients undergoing radical cystectomy for bladder cancer: a systematic review and meta-analysis of comparative studies.
    Bi L; Huang H; Fan X; Li K; Xu K; Jiang C; Liu H; Dong W; Zhang S; Yang X; Lin T; Huang J
    BJU Int; 2014 May; 113(5b):E39-48. PubMed ID: 24053715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node-positive bladder cancer.
    von Deimling M; Furrer M; Mertens LS; Mari A; van Ginkel N; Bacchiani M; Maas M; Pichler R; Li R; Moschini M; Bianchi A; Vetterlein MW; Lonati C; Crocetto F; Taylor J; Tully KH; Afferi L; Soria F; Del Giudice F; Longoni M; Laukhtina E; Antonelli A; Rink M; Fisch M; Lotan Y; Spiess PE; Black PC; Kiss B; Pradere B; Shariat SF;
    BJU Int; 2024 Mar; 133(3):341-350. PubMed ID: 37904652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy.
    Abdollah F; Sun M; Schmitges J; Djahangirian O; Tian Z; Jeldres C; Perrotte P; Shariat SF; Montorsi F; Karakiewicz PI
    BJU Int; 2012 Apr; 109(8):1147-54. PubMed ID: 21883849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
    J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival.
    Jensen JB; Ulhøi BP; Jensen KM
    Int J Urol; 2012 Jan; 19(1):39-47. PubMed ID: 22050425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study.
    Zehnder P; Studer UE; Skinner EC; Dorin RP; Cai J; Roth B; Miranda G; Birkhäuser F; Stein J; Burkhard FC; Daneshmand S; Thalmann GN; Gill IS; Skinner DG
    J Urol; 2011 Oct; 186(4):1261-8. PubMed ID: 21849183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma.
    Crozier J; Papa N; Perera M; Stewart M; Goad J; Sengupta S; Bolton D; Lawrentschuk N
    Investig Clin Urol; 2017 Nov; 58(6):416-422. PubMed ID: 29124240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node counts are valid indicators of the quality of surgical care in bladder cancer: a population-based study.
    Siemens DR; Mackillop WJ; Peng Y; Wei X; Berman D; Booth CM
    Urol Oncol; 2015 Oct; 33(10):425.e15-23. PubMed ID: 26199175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.
    Hwang EC; Sathianathen NJ; Imamura M; Kuntz GM; Risk MC; Dahm P
    Cochrane Database Syst Rev; 2019 May; 5(5):CD013336. PubMed ID: 31111956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoendoscopic Single-Site Radical Cystectomy vs Conventional Laparoscopic Radical Cystectomy for Patient with Bladder Urothelial Carcinoma: Matched Case-Control Analysis.
    Xu K; Lang B; Fu B; Shi T; Wang B; Zhang X
    J Endourol; 2017 Dec; 31(12):1259-1268. PubMed ID: 28967303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
    Stein JP; Cai J; Groshen S; Skinner DG
    J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy.
    Simone G; Papalia R; Ferriero M; Guaglianone S; Castelli E; Collura D; Muto G; Gallucci M
    Int J Urol; 2013 Apr; 20(4):390-7. PubMed ID: 22970939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes.
    Mistretta FA; Cyr SJ; Luzzago S; Mazzone E; Knipper S; Palumbo C; Tian Z; Nazzani S; Saad F; Montanari E; Tilki D; Briganti A; Shariat SF; de Cobelli O; Karakiewicz PI
    Clin Genitourin Cancer; 2020 Apr; 18(2):129-137.e3. PubMed ID: 32001182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A propensity-score-matched comparison of standard and extended pelvic lymph node dissection in robot-assisted laparoscopic radical cystectomy.
    Wei F; Li T; Zhang Y; Ding J; Zhang G; Li X; Gan W; Zhang S; Guo H; Yang R
    J Robot Surg; 2024 Jul; 18(1):295. PubMed ID: 39068352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer.
    Perera M; McGrath S; Sengupta S; Crozier J; Bolton D; Lawrentschuk N
    Nat Rev Urol; 2018 Nov; 15(11):686-692. PubMed ID: 30104615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
    J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robotic extended pelvic lymphadenectomy for bladder cancer with increased nodal yield.
    Lavery HJ; Martinez-Suarez HJ; Abaza R
    BJU Int; 2011 Jun; 107(11):1802-5. PubMed ID: 21070571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.